UHS Stock Analysis: Buy, Sell, or Hold?
UHS - Universal Health Services, Inc. Class B
$152.77
-2.80 (-1.80%)
▼
5d:
-3.34%
30d:
+5.49%
90d:
-15.49%
BUY
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Jul 27, 2026
12d
Get Alerted When UHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: UHS shows positive signals but monitor for confirmation. Market pricing in 7.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: UHS shows positive signals but monitor for confirmation. Market pricing in 7.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$256.16
Based on 5.8% avg growth
INTRINSIC VALUE TODAY
$159.06
4.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 7.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UHS is currently trading at $152.77, which is considered extended relative to its 30-day fair value range of $141.99 to $152.18. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.1) compared to its historical average (7.7). Remarkably, the market is currently pricing in an annual earnings decline of 7.6% over the next few years. This pessimistic expectation contrasts with the company's recent 17.7% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, UHS is in a strong downtrend. Immediate support is located at $140.08, while resistance sits at $159.52.
Market Sentiment: UHS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $208.29 (+36.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, UHS is in a strong downtrend. Immediate support is located at $140.08, while resistance sits at $159.52.
Market Sentiment: UHS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $208.29 (+36.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$141.99 -
$152.18
Company Quality Score
63/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 36.3% below Wall St target ($208.29)
Trading Range Analysis
30-Day Trading Range
$141.99 -
$152.18
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$140.08
Resistance Level
$159.52
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.07
Wall Street Target
$208.29
(+36.3%)
Revenue Growth (YoY)
9.6%
Earnings Growth (YoY)
17.7%
Profit Margin
8.6%
Valuation Discount vs History
-7.6% cheaper
PE vs Historical
6.1 vs 7.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.6%
(market-implied from PE analysis)
1-Year Target
$141.16
(-8%)
2-Year Target
$130.43
(-15%)
3-Year Target
$120.52
(-21%)
3-Yr Target (if PE normalizes)
(PE: 6→8)
$152.86
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 7.5%)
$680.51
(+345%)
Base:
(SPY PE: 6.1, Growth: 7.5%)
$189.69
(+24%)
Bear:
(PE: 5.2, Growth: 7.5%)
$161.24
(+6%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (7x PE), but valuation improves significantly next year (6x PE) as earnings recover.
Trailing PE: 6.50 | Current EPS (TTM): $23.94
Bull Case
$179.87
(+18%)
Analyst growth 5.1%, PE expands to 7.2
Base Case
$163.52
(+7%)
Market implied 5.1%, PE stable at 6.5
Bear Case
$105.79
(-31%)
Severe decline -20.0%, PE contracts to 5.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.1 to 7.7
Stabilization Target:
$193.76
(+26.8%)
PE Expansion Potential:
+26.8%
Share & Embed Analysis
Last updated: July 14, 2026 1:31 AM ET
Data refreshes hourly during market hours. Next update: 2:31 AM
Data refreshes hourly during market hours. Next update: 2:31 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UHS showing a specific setup today?
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-02-24
Ro Khanna
BUY
2026-01-29
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$244 | 62 BUY |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$494 | 61 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 58 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$24 | 53 HOLD |
|
OPCH
Option Care Health Inc |
STRONG BUY
10 analysts |
$29 | 64 BUY |
Advanced UHS Option Strategies
Professional options setups generated by AI based on today's UHS price and gamma walls.
